Anecortave Acetate Versus Placebo in AMD Patients Following PDT

Completed · Phase 2

Conditions studied: AMD

In brief

The purpose of this study was to evaluate the efficacy of anecortave acetate for depot suspension (30 mg and 15 mg) plus PDT versus PDT alone with respect to maintenance of visual acuity in patients with wet AMD.

Key facts

Study ID

NCT00346866

Run by

Alcon Research

People needed

136

Starts

2000-05-01

Expected to finish

2001-12-01

Last updated by the study team

2008-08-05

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• AMD disease

You may not qualify if…

• Age

Where it is running

• Facility — Beachwood, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.